Skip to content

Retention in pre-ART care can be boosted by monthly visits from volunteer support workers

Daclatasvir plus sofosbuvir cures HCV for most people with HIV and HCV co-infection in French compassionate use programme

Dominique Salmon at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Interferon-free hepatitis treatment is highly effective for people with HIV and HCV co-infection in three studies

David Wyles at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Intensification of antiretroviral therapy reduces risk of late-term mother-to-child HIV transmission

Implant and injectable hormonal contraception most effective methods for women living with HIV

Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection

Laurence Brunet at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Switching to new tenofovir alafenamide keeps virus in check and improves kidney and bone health

Tony Mills at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Raltegravir appears to prevent mother-to-child HIV transmission during late pregnancy

Fatima Kakkar at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

PrEP demo project finds the people at highest HIV risk generally take PrEP most consistently

Albert Liu at IAS 2015. Photo by Liz Highleyman, hivandhepatitis,com